Table 1 Clinical characteristics and surgical outcomes between fibroadenoma and non-fibroadenoma groups
From: Surgery for fibroadenoma arising from axillary accessory breast
AAB with fibroadenoma (n = 39) | AAB without fibroadenoma (n = 2271) | P-value* | |
|---|---|---|---|
Age, years | 34.3 (22–48) | 33.8 (13–65) | 0.687 |
Category | 0.372 | ||
≤ 20 | 0 (0.0) | 78 (3.4) | |
21–40 | 27 (69.2) | 1694 (74.6) | |
41–60 | 12 (30.8) | 490 (21.6) | |
> 60 | 0 (0.0) | 9 (0.4) | |
BMI, kg/m2 | 19.9 (15.5–24.1) | 22.3 (17.2–33.7) | < 0.000 |
Family history of AAB | 0.585 | ||
None | 37 (94.8) | 2043 (89.9) | |
Mother | 1 (2.6) | 136 (6.0) | |
Siblings | 1 (2.6) | 92 (4.1) | |
Symptoms | 0.148 | ||
Palpable mass | 0 (0.0) | 167 (7.3) | |
Pain and palpable mass | 39 (100.0) | 2104 (92.7) | |
Onset of symptoms | 0.008 | ||
After puberty | 31 (79.5) | 1294 (57.0) | |
After pregnancy | 8 (20.5) | 977 (43.0) | |
DL classification | 0.288 | ||
I | 29 (74.4) | 1408 (62.0) | |
A | 1 | 230 | |
B | 28 | 1170 | |
II | 8 (20.5) | 693 (30.5) | |
A | 2 | 110 | |
B | 6 | 583 | |
III | 2 (5.1) | 170 (7.5) | |
A | 1 | 70 | |
B | 1 | 100 | |
Concurrent fibroadenoma excision in the chest normal breast | 14 (35.9) | 92 (4.1) | < 0.000 |
Operation time, minutes | 39.4 (30–60) | 39.0 (30–60) | 0.905 |
Weight of the accessory mammary gland, g | 57.4 (25–157) | 59.9 (10–204) | 0.641 |
Liposuction volume, mL | 301.7 (60–600) | 338.6 (60–1200) | 0.759 |
Other tumor | 0 (0.0) | 5 (0.2) | 1.000 |
Fibrocystic disease | 0 | 5 | |
Malignancy | 0 | 0 | |
Postoperative complications | 1 (2.6) | 54 (2.4) | 0.986 |
Hematoma | 0 | 4 | |
Seroma | 1 | 20 | |
Surgical site infection | 0 | 1 | |
Skin ischemia | 0 | 6 | |
Axillary numbness | 0 | 3 | |
Hypertrophic scar | 0 | 4 | |
Hyperpigmentation | 0 | 10 | |
Irregular skin contour | 0 | 6 | |
Redo operation | 1 (2.6) | 60 (2.6) | 0.919 |
Redundant skin excision | 0 | 50 | |
Remnant mammary gland | 0 | 0 | |
Liposuction for irregular contour | 1 | 6 | |
Scar revision for hypertrophic scar | 0 | 4 | |
Postoperative fibroadenoma growth in axilla | 0 (0.0) | 0 (0.0) | |
Satisfaction scorea | |||
Appearance | 4.7 (4–5) | 4.7 (4–5) | 0.544 |
Axillary pain | 4.8 (4–5) | 4.7 (4–5) | 0.664 |
Overall | 9.4 (8–10) | 9.4 (9–10) | 0.687 |
Follow-up period | 41.6 (6–75) | 46.1 (6–75) | 0.376 |